Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
A common mechanism of Sec61 translocon inhibition by small molecules
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4665786
Author(s) Itskanov, Samuel; Wang, Laurie; Junne, Tina; Sherriff, Rumi; Xiao, Li; Blanchard, Nicolas; Shi, Wei Q.; Forsyth, Craig; Hoepfner, Dominic; Spiess, Martin; Park, Eunyong
Author(s) at UniBasel Spiess, Martin
Year 2023
Title A common mechanism of Sec61 translocon inhibition by small molecules
Journal Nature Chemical Biology
Volume 19
Number 9
Pages / Article-Number 1063-1071
Mesh terms Humans; Endoplasmic Reticulum, metabolism; Membrane Proteins, metabolism; Protein Transport, physiology; SEC Translocation Channels, metabolism
Abstract The Sec61 complex forms a protein-conducting channel in the endoplasmic reticulum membrane that is required for secretion of soluble proteins and production of many membrane proteins. Several natural and synthetic small molecules specifically inhibit Sec61, generating cellular effects that are useful for therapeutic purposes, but their inhibitory mechanisms remain unclear. Here we present near-atomic-resolution structures of human Sec61 inhibited by a comprehensive panel of structurally distinct small molecules-cotransin, decatransin, apratoxin, ipomoeassin, mycolactone, cyclotriazadisulfonamide and eeyarestatin. All inhibitors bind to a common lipid-exposed pocket formed by the partially open lateral gate and plug domain of Sec61. Mutations conferring resistance to the inhibitors are clustered at this binding pocket. The structures indicate that Sec61 inhibitors stabilize the plug domain in a closed state, thereby preventing the protein-translocation pore from opening. Our study provides the atomic details of Sec61-inhibitor interactions and the structural framework for further pharmacological studies and drug design.
Publisher Nature Publishing Group
ISSN/ISBN 1552-4450 ; 1552-4469
edoc-URL https://edoc.unibas.ch/94636/
Full Text on edoc Restricted
Digital Object Identifier DOI 10.1038/s41589-023-01337-y
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/37169959
ISI-Number WOS:000986854600004
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.391 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
05/05/2024